Episodic Migraine Study- Botox
If you live with the unpredictable pain of a migraine, you already know it is far more than a bad headache. It steals your time, drains your energy, and robs you of the moments that matter most – time with your family, your focus at work, your sense of normalcy. At Lone Star Neurology in Texas, we are currently enrolling participants in the MINT-C study, a migraine clinical trial designed for people who experience episodic migraine.
The primary goal of this research is to determine whether Xeomin (incobotulinumtoxinA) can meaningfully reduce the number of days you spend in pain each month. Participants receive injections into the muscles of the head and neck, and the effects of Xeomin are compared with a placebo to measure changes in monthly migraine days. The study runs approximately 52 to 55 weeks. If you are searching for a genuine migraine treatment near me and want to help advance medical science at the same time, we invite you to find out whether you qualify.
What Is an Episodic Migraine?
Understanding your diagnosis is the essential first step toward reclaiming control over your life. The pain may feel the same from one attack to the next, but physicians categorize migraine patients into two clinically distinct groups: episodic and chronic.
An episodic migraine diagnosis applies to individuals who experience 14 or fewer headache days per month. To meet the specific criteria for this study, between 6 and 14 of those monthly days must qualify as true migraine episodes. “Episodic” may sound less severe than “chronic” – but the impact on daily life is still profound. These attacks frequently involve intense throbbing pain, debilitating sensitivity to light and sound, and nausea severe enough to leave you confined to a dark room for hours or even days at a time.
One of the most serious concerns for patients in this category is the risk of progression. Without effective episodic migraine treatment, the brain can become increasingly sensitized over time, causing attacks to occur more and more frequently until the condition crosses into the chronic threshold – defined as 15 or more headache days per month. Taking proactive steps now, with the guidance of experienced specialists, can help you manage the condition before it reaches that stage and permanently disrupts your quality of life.
About the MINT-C Episodic Migraine Research Study
The MINT-C study is a dedicated research initiative aimed at identifying better therapeutic options for patients who struggle with frequent migraine attacks. This study examines how Xeomin – a form of botulinum toxin – performs when injected into specific muscles of the head and neck. Many patients are already familiar with Botox for episodic migraine as a treatment concept, and this study applies a comparable approach using Xeomin to evaluate whether it can effectively reduce attack frequency in episodic sufferers.
Upon enrollment, participants are randomly assigned to receive either the active study drug or a placebo. This randomized, controlled design is a cornerstone of high-quality clinical research – it ensures that the results are scientifically valid and free from bias. Total study participation spans approximately 52 to 55 weeks. Throughout this period, participants maintain a daily electronic headache diary, providing researchers with precise, real-time data on how symptoms change in response to treatment. This information is critical: it tells us exactly how well the Botox migraine protocol is working on an individual level.
Who May Be Eligible?
Not every patient who experiences headaches will qualify for episodic migraine treatment within this study. Eligibility criteria are carefully defined to ensure the consistency and reliability of the research data. You may be a strong candidate for the MINT-C study if you meet the following requirements:
- Age. You must be at least 18 years old.
- History. Your very first migraine episode must have occurred before the age of 50.
- Frequency. You have a documented history of 14 or fewer total headache days per month.
- Specifics. Of those headache days, at least 6 but no more than 14 must meet the clinical criteria for a migraine.
If this profile reflects your experience, it may be time to consult a migraine specialist near me at Lone Star Neurology. Please keep in mind that these represent only the initial screening requirements. Our clinical team will conduct a thorough, individualized evaluation to confirm that the study is both safe and appropriate for your specific health situation before any commitment is made.
What to Expect as a Study Participant
Entering a migraine clinical trial can feel like a significant step. Our team at Lone Star Neurology is here to guide you clearly and confidently through every stage of the process.
It begins with a screening visit during which we review your complete medical history and current symptom pattern. If you meet the eligibility criteria, you will enter a baseline period – a defined window in which you track your headaches daily to establish an accurate starting point for comparison.
Once the baseline phase is complete, you will move into the active treatment phase. A board-certified neurologist will oversee your care and administer the injections into the targeted muscles of the head and neck. You will continue using the daily electronic diary throughout, providing an ongoing record of your real-world experience with episodic migraine prevention. Regular assessment visits are scheduled throughout the year-long study so that our medical team can monitor your health and track your progress closely at every step.
Benefits and Risks of Participation
Every medical study involves a careful balance of potential benefits and inherent risks. We believe that fully understanding both sides is essential before making any commitment.
Potential benefits include:
- Access to investigational Botox for episodic migraine therapy using Xeomin at no personal cost
- Intensive, expert neurological monitoring by physicians who specialize exclusively in headache medicine
- The opportunity to contribute to a body of scientific evidence that could provide relief for millions of people in the future
Potential risks to be aware of:
- As with any injection-based procedure, some participants may experience localized pain, redness, or bruising at the injection site.
- A small number of patients report Botox migraine side effects, such as temporary muscle weakness in the neck or shoulders, or a transient sensation of heaviness in the forehead.
- As with any investigational therapy, there is no guarantee that the treatment will reduce your personal headache frequency to the degree you are hoping for.
Our clinical team will walk you through each of these points in full detail during the informed consent process. We are committed to ensuring that every participant makes a fully informed, confident decision about their own health – with no pressure and no ambiguity.
How to Apply - Contact Lone Star Neurology
We are actively enrolling new participants and would welcome the opportunity to speak with you. If you have been searching for a clinical trial near me or exploring options for a migraine treatment near me that goes beyond conventional approaches, the MINT-C study may be exactly what you have been looking for.
To begin, complete our “Click to Apply” form on the Lone Star Neurology website. The form asks a brief set of screening questions to help us assess your initial eligibility:
- Your name and contact information (phone and email)
- Your date of birth (to confirm you are 18 or older)
- Confirmation that your migraines began before the age of 50
- An estimate of your monthly headache and migraine days (the study targets the 6-14 range)
- Your willingness to maintain a daily electronic headache diary
Once your form is submitted, a study coordinator will contact you promptly to explain the next steps and answer any questions you may have about the Botox migraine study process.
Contact Information:
- Phone: 214-619-1910
- Location: Lone Star Neurology, Texas
- Official Study Registry: ClinicalTrials.gov – identifier NCT07018700
Choosing to take part in a clinical study is a meaningful, courageous step toward taking control of your health. By exploring a therapy like Xeomin through the MINT-C program, you are moving toward a future in which migraines no longer determine your schedule or define your days. Reach out to Lone Star Neurology today and find out whether this study is the right fit for you.
